1. Home
  2. CMPS vs EHAB Comparison

CMPS vs EHAB Comparison

Compare CMPS & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$5.49

Market Cap

778.7M

Sector

Health Care

ML Signal

HOLD

Logo Enhabit Inc.

EHAB

Enhabit Inc.

HOLD

Current Price

$13.66

Market Cap

690.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPS
EHAB
Founded
2020
2014
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
778.7M
690.9M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
CMPS
EHAB
Price
$5.49
$13.66
Analyst Decision
Strong Buy
Hold
Analyst Count
8
5
Target Price
$27.14
$13.84
AVG Volume (30 Days)
2.4M
1.7M
Earning Date
03-24-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
97.11
EPS
N/A
N/A
Revenue
N/A
$1,060,000,000.00
Revenue This Year
N/A
$6.42
Revenue Next Year
N/A
$4.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.44
52 Week Low
$2.25
$6.47
52 Week High
$8.90
$13.66

Technical Indicators

Market Signals
Indicator
CMPS
EHAB
Relative Strength Index (RSI) 36.12 79.43
Support Level $4.78 $10.79
Resistance Level $7.02 N/A
Average True Range (ATR) 0.40 0.03
MACD -0.16 -0.11
Stochastic Oscillator 21.37 87.50

Price Performance

Historical Comparison
CMPS
EHAB

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.

Share on Social Networks: